Resident Researchers PGY-1 PGY-2. Kristen Schroeder

Transcription

1 Resident Researchers PGY-1 Kristen Schroeder PGY-2 Stanley Brewer 1) Evaluation of psychopharmacologic treatment of children with prenatal exposure to drugs of abuse. Submitted for publication, under review. Faculty: Dr. Hulvershorn. 1) Cystic Fibrosis depression screening. Starting screening of CF patients for depression in the outpatient setting. Aim is to start with increasing the identification of depression in this population, then evaluate treatment effects, compliance, and outcomes. Faculty: Dr. Howensine, pediatric pulmonology.

2 Semyon Faynboym 1) Genetic Testing in Pain Medicine, submitted for review to Pain Physician. -Collaboration with Dr. Andrea Trescot of Eagle River, AK. PGY-3 Kristen Dauss 1) BMI improvement & antipsychotic weaning (no official title). Faculty: Dr. Hulvershorn. 2) Lactation & impact on Edinburgh score. Faculty: Dr. Szucz (Pediatrics).

3 Jess Levy 1) Submitted a paper to the Journal of Attention Disorders (JAD) titled, "Development of a Very Brief Measure of ADHD: The Chaos Scale". The article was submitted and revised following peer review and has been accepted for publication. Faculty mentor: Dr. Kronenberger. 2) I am investigating the role of mental health on primary care resident's perceived comfort in treating psychiatric comorbidities. Following IRB approval, we sent out a brief, anonymous online survey to internal medicine residents across the Midwest asking them to describe their current access to mental health professionals in their primary clinic and rate their comfort level in various domains of psychiatry (medication management, addictions, etc). Faculty mentors: Dr. J Chambers and Dr. Hackman. GenaLynne Mooneyham 1) ADHD Group Visit Research Trial Faculty: Dr. Dorota Szczepaniak, Dr. Paula Sullivan (PhD), and Dr. Nerissa Bauer (Developmental & Behavioral Pediatrics) Accepted for presentation to American Academy of Pediatrics ADHD Special Interest Group annual conference in Sept ) Anorexia Nervosa standardized fluid resuscitation protocol August 2012-current Current Faculty: Dr. Theresa Rohr-Kirchgraber (Internal Medicine) and Dr. Mary Rouse (Pediatrics- Adolescent Medicine) Initial case report Poster Presentation: "Busting a gut... literally: Malnutrition a Cause of Gastric Distention". Presented at the American Medical Women's Association Annual Conference in New York, NY. March 2013.

4 Niclaire Neely 1) Writing a book chapter for criminology book on the topic of behavioral genetics of anti-social personality disorder. Faculty: Dr. Gunter. Stephanie Price 1) Trials of Concerta in kids with chronic irritability and combined ADHD diagnosis. Looking at reduction of irritability with use of a stimulant. Faculty: Dr. Hulvershorn. 2) Trial of Minocycline in reducing both positive and negative symptoms in small study of patients with chronic Schizophrenia. Will be evaluating improvement with rating scales for psychosis, social performance, and negative symptoms. Faculty Mentors: Dr. Radnovich, Dr. Liffick, Dr. Francis.

5 Matthew Runyan 1) Publication: Cortical striatal gene expression in neonatal hippocampal lesion (NVHL)-amplified cocaine sensitization (pages ) R. A. Chambers, J. N. McClintick, A. M. Sentir, S. A. Berg, M. Runyan, K. H. Choi and H. J. Edenberg Article first published online: 22 JUN 2013 DOI: /gbb ) Ongoing clinical trial, involved in data collection and clinical evaluations: BETA: study for the use of estrogen receptor beta agonist to reduce cognitive and negative symptoms of schizophrenia in early stage psychosis. Faculty: Dr. Breier, Dr. Liffick. 3) Ongoing clinical trial, involved in data collection and clinical evaluations STEP: Use of fingolimod to evaluate reduction in psychotic symptoms. Faculty: Dr. Breier, Dr. Liffick. 4) Ongoing clinical trial, involved in data collection and clinical evaluations: STANLEY reduction in cortical erosion in patients with early stage psychosis through the use of N-Acetyl Cysteine. Faculty advisors: Dr. Breier and Dr. Liffick. 5) Ongoing prospective trial: Prediction of violence in outpatient setting during early stage psychosis. Faculty: Dr. Breier, Dr. Liffick, Dr. Francis. 6) Retrospective data review Can violence risk prediction be evaluated in early stage psychosis patients? A retrospective review of research population. Faculty: Dr. Breier, Dr. Liffick, Dr. Francis.

6 PGY-4 Yokesh Balaraman 1) PGBD study - Pharmacogenomics of Mood Stabilizer response in Bipolar I patients. This is part of Multi-Center study coordinated by UCSD and funded by NIMH and NIGMS. Primary Investigator: Dr. Nurnberger. 2) Molecular changes in synaptic proteins by glutamate modulating drugs in neuronal cell culture model. Primary Investigator: Dr. Lahiri. Carolyn Doyle 1) Doyle, C.A., McDougle, C.J. (2012). Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dialogues in Clinical Neuroscience (in press). 2) Doyle, C.A., McDougle, C.J. (2012). Pharmacotherapy to control behavioural symptoms in autistic children. Expert Opinion on Pharmacotherapy, 13(11), ) Doyle, C. A., Stigler, K.A., McDougle, C.J. (2012). Chapter 8: Pharmacotherapy of Behavioral Symptoms and Psychiatric Comorbidities in Adolescents and Adults with Autism Spectrum Disorder. Adolescents and Adults with Autism. (in press).

7 Joshua Goergen 1) Ongoing clinical trial, involved in data collection and clinical evaluations: BETA: study for the use of estrogen receptor beta agonist to reduce cognitive and negative symptoms of schizophrenia in early stage psychosis. Faculty: Dr. Breier, Dr. Liffick. 2) Ongoing clinical trial, involved in data collection and clinical evaluations STEP: Use of fingolimod to evaluate reduction in psychotic symptoms. Faculty: Dr. Breier, Dr. Liffick. Amber Hunt 3) Ongoing clinical trial, involved in data collection and clinical evaluations: STANLEY reduction in cortical erosion in patients with early stage psychosis through the use of N-Acetyl Cysteine. Faculty advisors: Dr. Breier and Dr. Liffick. 1) Evaluation of cognitive training and benefits for children with ADHD. Submitted a proposal for poster presentation to AACAP 2013.

8 Mallery Neff Ashley Overley 1) Review of the Adverse Childhood Experiences Score. Faculty: Dr. R.A. Chambers. 1) "Assessment of family-specific barriers to family participation in care for early psychosis patients" Ongoing research project. Faculty Mentors: Dr. Saylers, Dr. Minor, Dr. Liffick, Dr. Breier. 2) Ongoing clinical trial, involved in data collection and clinical evaluations: BETA: study for the use of estrogen receptor beta agonist to reduce cognitive and negative symptoms of schizophrenia in early stage psychosis. Faculty: Dr. Breier, Dr. Liffick. 3) Ongoing clinical trial, involved in data collection and clinical evaluations STEP: Use of fingolimod to evaluate reduction in psychotic symptoms. Faculty: Dr. Breier, Dr. Liffick. 4) Ongoing clinical trial, involved in data collection and clinical evaluations: STANLEY reduction in cortical erosion in patients with early stage psychosis through the use of N-Acetyl Cysteine. Faculty advisors: Dr. Breier and Dr. Liffick.

9 Venkat Polavarapu 1) Ongoing clinical trial, involved in data collection and clinical evaluations: BETA: study for the use of estrogen receptor beta agonist to reduce cognitive and negative symptoms of schizophrenia in early stage psychosis. Faculty: Dr. Breier, Dr. Liffick. 2) Ongoing clinical trial, involved in data collection and clinical evaluations STEP: Use of fingolimod to evaluate reduction in psychotic symptoms. Faculty: Dr. Breier, Dr. Liffick. Rachel Yoder 3) Ongoing clinical trial, involved in data collection and clinical evaluations: STANLEY reduction in cortical erosion in patients with early stage psychosis through the use of N-Acetyl Cysteine. Faculty advisors: Dr. Breier and Dr. Liffick. 1) Review of the Adverse Childhood Experiences Score. Faculty: Dr. R.A. Chambers.